Back to search
FDAFDA · Food and drugs·Recall number D-0024-2019

Thyroid, USP (Full Strength) Levothyroxine 112.1 mcg/grain Liothyronine 29.2 mcg/grain Active Pharmaceutical Ingredient Rx Only 1000 grams NDC 0395-6580-43 Packaged by: Humco Texarkana, TX 75501 USA

Published October 24, 2018 · Recall initiated: August 28, 2018

Summary

FDA records drug Class II recall D-0024-2019, published October 24, 2018 and initiated August 28, 2018. Recalling firm: Humco Holding Group, Inc; Status: Terminated; Reported quantity: 10 kilograms; Lot: Lot: A26450 Exp. 05/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Humco Holding Group, Inc
Distributor
Nationwide.
Lot
Lot: A26450 Exp. 05/2019
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Thyroid, USP (Full Strength) Levothyroxine 112.1 mcg/grain Liothyronine 29.2 mcg/grain Active Pharmaceutical Ingredient Rx Only 1000 grams NDC 0395-6580-43 Packaged by: Humco Texarkana, TX 75501 USA recalled?

Yes. FDA published recall D-0024-2019 on October 24, 2018. Reported hazard: CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

What should I do if I have this product?

Voluntary: Firm initiated · Letter